The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
Joanne Linda Yu
No relevant relationships to disclose
Michael Kurin
No relevant relationships to disclose
Mark Pasetka
No relevant relationships to disclose
Srikala S. Sridhar
No relevant relationships to disclose
Ellen Warner
No relevant relationships to disclose